Skip to main content

Advertisement

SpringerLink
Log in

Predicting severity of acute pancreatitis

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Severity stratification is a critical issue in acute pancreatitis that strongly influences diagnostic and therapeutic decision making. According to the widely used Atlanta classification, “severe” disease comprises various local and systemic complications that are associated with an increased risk of mortality. However, results from recent clinical studies indicate that these complications vary in their effect on outcome, and many are not necessarily life threatening on their own. Therefore, “severe,” as defined by Atlanta, must be distinguished from “prognostic,” aiming at nonsurvival. In the first week after disease onset, pancreatitis-related organ failure is the preferred variable for predicting severity and prognosis because it outweighs morphologic complications. Contrast-enhanced CT and MRI allow for accurate stratification of local severity beyond the first week after symptom onset. Among the biochemical markers, C-reactive protein is still the parameter of choice to assess attack severity, although prognostic estimation is not possible. Other markers, including pancreatic protease activation peptides, interleukins-6 and-8, and polymorphonuclear elastase are useful early indicators of severity. Procalcitonin is one of the most promising single markers for assessment of major complications and prognosis throughout the disease course.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Sarles H: Proposal adopted unanimously by the participants of the symposium on pancreatitis at Marseille, 1963. Bibl Gastroenterol 1965, 7:VII–VIII.

    Google Scholar 

  2. Bradley EL III: A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993, 128:586–590.

    Article  PubMed  Google Scholar 

  3. Lankisch PG, Schirren CA: Increased body weight as a prognostic parameter for complications in the course of acute pancreatitis. Pancreas 1990, 5:626–629.

    Article  CAS  PubMed  Google Scholar 

  4. Martinez J, Johnson CD, Sanchez-Paya J, et al.: Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology 2006, 6:206–209.

    Article  CAS  PubMed  Google Scholar 

  5. Leppaniemi A, Kemppainen E: Recent advances in the surgical management of necrotizing pancreatitis. Curr Opin Crit Care 2005, 11:349–352.

    Article  PubMed  Google Scholar 

  6. Tao HQ, Zhang JX, Zou SC: Clinical characteristics and management of patients with early acute severe pancreatitis: experience from a medical center in China. World J Gastroenterol 2004, 10:919–921.

    PubMed  Google Scholar 

  7. De Waele JJ, Hoste E, Blot SI, et al.: Intra-abdominal hypertension in patients with severe acute pancreatitis. Crit Care 2005, 9:R452–R457.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Isenmann R, Rau B, Beger HG: Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas 2001, 22:274–278.

    Article  CAS  PubMed  Google Scholar 

  9. Buter A, Imrie CW, Carter CR, et al.: Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg 2002, 89:298–302.

    Article  CAS  PubMed  Google Scholar 

  10. Johnson CD, Abu-Hilal M: Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 2004, 53:1340–1344.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Poves Prim I, Fabregat Pous J, Garcia Borobia FJ, et al.: Early onset of organ failure is the best predictor of mortality in acute pancreatitis. Rev Esp Enferm Dig 2004, 96:705–713.

    Article  CAS  PubMed  Google Scholar 

  12. Rau BM, Bothe A, Kron M, Beger HG: Role of early multisystem organ failure as major risk factor for pancreatic infections and death in severe acute pancreatitis. Clin Gastroenterol Hepatol 2006, 4:1053–1061.

    Article  PubMed  Google Scholar 

  13. Mofidi R, Duff MD, Wigmore SJ, et al.: Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg 2006, 93:738–744.

    Article  CAS  PubMed  Google Scholar 

  14. Le Mee J, Paye F, Sauvanet A, et al.: Incidence and reversibility of organ failure in the course of sterile or infected necrotizing pancreatitis. Arch Surg 2001, 136:1386–1390.

    Article  PubMed  Google Scholar 

  15. Flint R, Windsor JA: Early physiological response to intensive care as a clinically relevant approach to predicting the outcome in severe acute pancreatitis. Arch Surg 2004, 139:438–443.

    Article  PubMed  Google Scholar 

  16. Satoh A, Miura T, Satoh K, et al.: Human leukocyte antigen-DR expression on peripheral monocytes as a predictive marker of sepsis during acute pancreatitis. Pancreas 2002, 25:245–250.

    Article  PubMed  Google Scholar 

  17. Mentula P, Kylanpaa-Back ML, Kemppainen E, et al.: Decreased HLA (human leucocyte antigen)-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis. Clin Sci (Lond) 2003, 105:409–417.

    Article  CAS  Google Scholar 

  18. Ho YP, Sheen IS, Chiu CT, et al.: A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am J Gastroenterol 2006, 101:1117–1124.

    Article  CAS  PubMed  Google Scholar 

  19. Kylanpaa ML, Mentula P, Kemppainen E, et al.: Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro. Pancreas 2005, 31:23–27.

    Article  CAS  PubMed  Google Scholar 

  20. Leger L, Chiche B, Louvel A: Pancreatic necrosis and acute pancreatitis. World J Surg 1981, 5:315–317.

    Article  CAS  PubMed  Google Scholar 

  21. Jimenez H, Aldrete JS: Clinical implications derived from the morphological classification of 89 patients with acute pancreatitis. J Clin Gastroenterol 1983, 5:137–142.

    Article  CAS  PubMed  Google Scholar 

  22. Beger HG, Bittner R, Block S, Buchler M: Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 1986, 91:433–438.

    CAS  PubMed  Google Scholar 

  23. Uhl W, Warshaw A, Imrie C, et al.: IAP guidelines for the surgical management of acute pancreatitis. Pancreatology 2002, 2:565–573.

    Article  PubMed  Google Scholar 

  24. UK guidelines for the management of acute pancreatitis. Gut 2005, 54(Suppl 3) 1–9.

  25. Zhu AJ, Shi JS, Sun XJ: Organ failure associated with severe acute pancreatitis. World J Gastroenterol 2003, 9:2570–2573.

    PubMed  Google Scholar 

  26. Kong L, Santiago N, Han TQ, Zhang SD: Clinical characteristics and prognostic factors of severe acute pancreatitis. World J Gastroenterol 2004, 10:3336–3338.

    PubMed  Google Scholar 

  27. Perez A, Whang EE, Brooks DC, et al.: Is severity of necrotizing pancreatitis increased in extended necrosis and infected necrosis? Pancreas 2002, 25:229–233.

    Article  PubMed  Google Scholar 

  28. Halonen KI, Pettila V, Leppaniemi AK, et al.: Multiple organ dysfunction associated with severe acute pancreatitis. Crit Care Med 2002, 30:1274–1279.

    Article  PubMed  Google Scholar 

  29. Runzi M, Niebel W, Goebell H, et al.: Severe acute pancreatitis: nonsurgical treatment of infected necroses. Pancreas 2005, 30:195–199.

    Article  PubMed  Google Scholar 

  30. Arvanitakis M, Delhaye M, De Maertelaere V, et al.: Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis. Gastroenterology 2004, 126:715–723.

    Article  PubMed  Google Scholar 

  31. Larvin M, McMahon MJ: APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989, 2:201–205.

    Article  CAS  PubMed  Google Scholar 

  32. Marshall JC, Cook DJ, Christou NV, et al.: Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995, 23:1638–1652.

    Article  CAS  PubMed  Google Scholar 

  33. Vincent JL, de Mendonca A, Cantraine F, et al.: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26:1793–1800.

    Article  CAS  PubMed  Google Scholar 

  34. Halonen KI, Leppaniemi AK, Lundin JE, et al.: Predicting fatal outcome in the early phase of severe acute pancreatitis by using novel prognostic models. Pancreatology 2003, 3:309–315.

    Article  PubMed  Google Scholar 

  35. Rau BM, Kemppainen E, Bassi C, et al.: Assessment of major complications and overall prognosis by the SOFA-, APACHEII-and MOF-Score in severe acute pancreatitis: Results of an international multicenter study [abstract]. Pancreatology 2005, 5:76.

    Google Scholar 

  36. Trapnell JE: The natural history and prognosis of acute pancreatitis. Ann R Coll Surg Engl 1966, 38:265–287.

    CAS  PubMed Central  PubMed  Google Scholar 

  37. Rau B, Schilling MK, Beger HG: Laboratory markers of severe acute pancreatitis. Dig Dis 2004, 22:247–257.

    Article  CAS  PubMed  Google Scholar 

  38. Borgstrom A, Appelros S, Muller CA, et al.: Role of activation peptides from pancreatic proenzymes in the diagnosis and prognosis of acute pancreatitis. Surgery 2002, 131:125–128.

    Article  PubMed  Google Scholar 

  39. Gudgeon AM, Heath DI, Hurley P, et al.: Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990, 335:4–8.

    Article  CAS  PubMed  Google Scholar 

  40. Tenner S, Fernandez-del Castillo C, Warshaw A, et al.: Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997, 21:105–110.

    CAS  PubMed  Google Scholar 

  41. Neoptolemos JP, Kemppainen EA, Mayer JM, et al.: Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000, 355:1955–1960.

    Article  CAS  PubMed  Google Scholar 

  42. Johnson CD, Lempinen M, Imrie CW, et al.: Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. Br J Surg 2004, 91:1027–1033.

    Article  CAS  PubMed  Google Scholar 

  43. Appelros S, Petersson U, Toh S, et al.: Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis. Br J Surg 2001, 88:216–221.

    Article  CAS  PubMed  Google Scholar 

  44. Muller CA, Appelros S, Uhl W, et al.: Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases. Gut 2002, 51:229–235.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Saez J, Martinez J, Trigo C, et al.: Comparative study of the activation peptide of carboxypeptidase B and trypsinogen as early predictors of the severity of acute pancreatitis. Pancreas 2004, 29:e9–e14.

    Article  CAS  PubMed  Google Scholar 

  46. Mayer JM, Raraty M, Slavin J, et al.: Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg 2002, 89:163–171.

    Article  CAS  PubMed  Google Scholar 

  47. Wilson C, Heads A, Shenkin A, Imrie CW: C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989, 76:177–181.

    Article  CAS  PubMed  Google Scholar 

  48. Mentula P, Kylanpaa ML, Kemppainen E, et al.: Early prediction of organ failure by combined markers in patients with acute pancreatitis. Br J Surg 2005, 92:68–75.

    Article  CAS  PubMed  Google Scholar 

  49. Rau B, Steinbach G, Baumgart K, et al.: Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant. Crit Care Med 2000, 28:736–742.

    Article  CAS  PubMed  Google Scholar 

  50. Mayer J, Rau B, Gansauge F, Beger HG: Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000, 47:546–552.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  51. Brivet FG, Emilie D, Galanaud P: Pro-and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 1999, 27:749–755.

    Article  CAS  PubMed  Google Scholar 

  52. Chen CC, Wang SS, Lee FY, et al.: Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol 1999, 94:213–218.

    Article  CAS  PubMed  Google Scholar 

  53. Dugernier TL, Laterre PF, Wittebole X, et al.: Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Am J Respir Crit Care Med 2003, 168:148–157.

    Article  PubMed  Google Scholar 

  54. Stimac D, Fisic E, Milic S, et al.: Prognostic values of IL-6, IL-8, and IL-10 in acute pancreatitis. J Clin Gastroenterol 2006, 40:209–212.

    Article  CAS  PubMed  Google Scholar 

  55. Pezzilli R, Billi P, Miniero R, et al.: Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci 1995, 40:2341–2348.

    Article  CAS  PubMed  Google Scholar 

  56. Rau B, Steinbach G, Gansauge F, et al.: The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997, 41:832–840.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  57. Gross V, Scholmerich J, Leser HG, et al.: Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin. Dig Dis Sci 1990, 35:97–105.

    Article  CAS  PubMed  Google Scholar 

  58. Viedma JA, Perez-Mateo M, Agullo J, et al.: Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut 1994, 35:822–827.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  59. Dominguez-Munoz JE, Carballo F, Garcia MJ, et al.: Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicenter study. BR J Surg 1991, 78:1230–1234.

    Article  CAS  PubMed  Google Scholar 

  60. Dominguez-Munoz JE, Villanueva A, Larino J, et al.: Accuracy of plasma levels of polymorphonuclear elastase as early prognostic marker of acute pancreatitis in routine clinical conditions. Eur J Gastroenterol Hepatol 2006, 18:79–83.

    Article  PubMed  Google Scholar 

  61. Maeda K, Hirota M, Ichihara A, et al.: Applicability of disseminated intravascular coagulation parameters in the assessment of the severity of acute pancreatitis. Pancreas 2006, 32:87–92.

    Article  PubMed  Google Scholar 

  62. Radenkovic D, Bajec D, Karamarkovic A, et al.: Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis. Pancreas 2004, 29:152–156.

    Article  PubMed  Google Scholar 

  63. Simon L, Gauvin F, Amre DK, et al.: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004, 39:206–217.

    Article  CAS  PubMed  Google Scholar 

  64. Rau B, Kruger CM, Schilling MK: Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis. Langenbecks Arch Surg 2004, 389:134–144.

    Article  CAS  PubMed  Google Scholar 

  65. Kylanpaa-Back ML, Takala A, Kemppainen EA, et al.: Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001, 29:63–69.

    Article  CAS  PubMed  Google Scholar 

  66. Kylanpaa-Back ML, Takala A, Kemppainen E, et al.: Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg 2001, 88:222–227.

    Article  CAS  PubMed  Google Scholar 

  67. Rau B, Kemppainen E, Gumb A, et al.: Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): A prospective international multicenter study Ann Surg 2007, 245, in press.

  68. Purkayastha S, Chow A, Athanasiou T, et al.: Does serum procalcitonin have a role in evaluating the severity of acute pancreatitis? A question revisited. World J Surg 2006, 30:1713–1721.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General, Visceral, and Vascular Surgery, University of the Saarland, Kirrberger Strasse, Building 57, 66421, Homburg/Saar, Germany

    Bettina M. Rau MD

Authors
  1. Bettina M. Rau MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bettina M. Rau MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rau, B.M. Predicting severity of acute pancreatitis. Curr Gastroenterol Rep 9, 107–115 (2007). https://doi.org/10.1007/s11894-007-0004-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-007-0004-5

Keywords

Search

Navigation